Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia

被引：27

作者：

Prebet, Thomas ^{[1
]}

Bertoli, Sarah ^{[2
]}

Delaunay, Jacques ^{[3
]}

Pigneux, Arnaud ^{[4
]}

Delabesse, Eric ^{[5
]}

Mozziconacci, Marie Joelle ^{[6
]}

Bidet, Audrey ^{[7
]}

Recher, Christian ^{[2
,8
]}

Vey, Norbert ^{[1
,9
]}

机构：

[1] Inst Paoli Calmettes, Dept Hematol, Marseille, France

[2] Inst Univ Canc Toulouse Oncopole, Dept Hematol, Toulouse 9, France

[3] Ctr Hospital Univ, Dept Hematol, Nantes, France

[4] Ctr Hosp Haut Leveque, Dept Hematol, Pessac, France

[5] Ctr Hosp Purpan, Genet Lab, Toulouse, France

[6] Inst Paoli Calmettes, Lab Biopathol, Marseille, France

[7] Ctr Hosp Haut Leveque, Lab Hematol Biolog, Pessac, France

[8] Inst Univ Canc Toulouse Oncopole, Lab Hematol, Toulouse, France

[9] Univ Aix Marseille, Marseille, France

来源：

HAEMATOLOGICA | 2014年 / 99卷 / 10期

关键词：

daunorubicin intensification; CBF; AML; MINIMAL RESIDUAL DISEASE; RISK STRATIFICATION; ADULT PATIENTS; AML; RECOMMENDATIONS; CYTARABINE; GEMTUZUMAB; DIAGNOSIS; RELAPSE;

D O I：

10.3324/haematol.2014.109827

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E185 / E187

页数：3

共 14 条

[1] Prognostic index for adult patients with acute myeloid leukemia in first relapse [J].

Breems, DA ;

Van Putten, WLJ ;

Huijgens, PC ;

Ossenkoppele, GJ ;

Verhoef, GEG ;

Verdonck, LF ;

Vellenga, E ;

De Greef, G ;

Jacky, E ;

Van der Lelie, J ;

Boogaerts, MA ;

Löwenberg, B .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1969-1978

[2] Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial [J].

Burnett, Alan K. ;

Hills, Robert K. ;

Milligan, Donald ;

Kjeldsen, Lars ;

Kell, Jonathan ;

Russell, Nigel H. ;

Yin, John A. L. ;

Hunter, Ann ;

Goldstone, Anthony H. ;

Wheatley, Keith .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :369-377

[3] Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22):: Results from CALGB 8461 [J].

Byrd, JC ;

Ruppert, AS ;

Mrózek, K ;

Carroll, AJ ;

Edwards, CG ;

Arthur, DC ;

Pettenatti, MJ ;

Stamberg, J ;

Koduru, PRK ;

Moore, JO ;

Mayer, RJ ;

Davey, FR ;

Larson, RA ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1087-1094

[4] Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study [J].

Castaigne, Sylvie ;

Pautas, Cecile ;

Terre, Christine ;

Raffoux, Emmanuel ;

Bordessoule, Dominique ;

Bastie, Jean-Noel ;

Legrand, Ollivier ;

Thomas, Xavier ;

Turlure, Pascal ;

Reman, Oumedaly ;

de Revel, Thierry ;

Gastaud, Lauris ;

de Gunzburg, Noemie ;

Contentin, Nathalie ;

Henry, Estelle ;

Marolleau, Jean-Pierre ;

Aljijakli, Ahmad ;

Rousselot, Philippe ;

Fenaux, Pierre ;

Preudhomme, Claude ;

Chevret, Sylvie ;

Dombret, Herve .

LANCET, 2012, 379 (9825) :1508-1516

[5] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[6]

Devillier R, 2013, BLOOD, V122

[7] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].

Doehner, Hartmut ;

Estey, Elihu H. ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Burnett, Alan K. ;

Dombret, Herve ;

Fenaux, Pierre ;

Grimwade, David ;

Larson, Richard A. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel A. ;

Sierra, Jorge ;

Tallman, Martin S. ;

Loewenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2010, 115 (03) :453-474

[8] Anthracycline Dose Intensification in Acute Myeloid Leukemia [J].

Fernandez, Hugo F. ;

Sun, Zhuoxin ;

Yao, Xiaopan ;

Litzow, Mark R. ;

Luger, Selina M. ;

Paietta, Elisabeth M. ;

Racevskis, Janis ;

Dewald, Gordon W. ;

Ketterling, Rhett P. ;

Bennett, John M. ;

Rowe, Jacob M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1249-1259

[9] Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia [J].

Jourdan, Eric ;

Boissel, Nicolas ;

Chevret, Sylvie ;

Delabesse, Eric ;

Renneville, Aline ;

Cornillet, Pascale ;

Blanchet, Odile ;

Cayuela, Jean-Michel ;

Recher, Christian ;

Raffoux, Emmanuel ;

Delaunay, Jacques ;

Pigneux, Arnaud ;

Bulabois, Claude-Eric ;

Berthon, Celine ;

Pautas, Cecile ;

Vey, Norbert ;

Lioure, Bruno ;

Thomas, Xavier ;

Luquet, Isabelle ;

Terre, Christine ;

Guardiola, Philippe ;

Bene, Marie C. ;

Preudhomme, Claude ;

Ifrah, Norbert ;

Dombret, Herve .

BLOOD, 2013, 121 (12) :2213-2223

[10] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia [J].

Lowenberg, Bob ;

Ossenkoppele, Gert J. ;

van Putten, Wim ;

Schouten, Harry C. ;

Graux, Carlos ;

Ferrant, Augustin ;

Sonneveld, Pieter ;

Maertens, Johan ;

Jongen-Lavrencic, Mojca ;

von Lilienfeld-Toal, Marie ;

Biemond, Bart J. ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

Verdonck, Leo F. ;

Beck, Joachim ;

Doehner, Hartmut ;

Gratwohl, Alois ;

Pabst, Thomas ;

Verhoef, Gregor .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1235-1248

← 1 2 →